chr13-31200145-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_194318.4(B3GLCT):āc.61T>Gā(p.Cys21Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000059 in 1,355,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_194318.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
B3GLCT | NM_194318.4 | c.61T>G | p.Cys21Gly | missense_variant | 1/15 | ENST00000343307.5 | |
B3GLCT | XM_011534936.2 | c.61T>G | p.Cys21Gly | missense_variant | 1/14 | ||
B3GLCT | XM_047430111.1 | c.61T>G | p.Cys21Gly | missense_variant | 1/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
B3GLCT | ENST00000343307.5 | c.61T>G | p.Cys21Gly | missense_variant | 1/15 | 1 | NM_194318.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000666 AC: 1AN: 150100Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000581 AC: 7AN: 1205548Hom.: 0 Cov.: 30 AF XY: 0.00000843 AC XY: 5AN XY: 593052
GnomAD4 genome AF: 0.00000666 AC: 1AN: 150100Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73262
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2022 | The c.61T>G (p.C21G) alteration is located in exon 1 (coding exon 1) of the B3GLCT gene. This alteration results from a T to G substitution at nucleotide position 61, causing the cysteine (C) at amino acid position 21 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at